OncoMatch

OncoMatch/Clinical Trials/NCT05500391

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Is NCT05500391 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for stage i testicular seminoma.

Phase 2RecruitingCentre Oscar LambretNCT05500391Data as of May 2026

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).

Check if I qualify

Extracted eligibility criteria

Cancer type

Testicular Germ Cell Tumor

Gastrointestinal Stromal Tumor

Glioblastoma

Neuroendocrine Tumor

Disease stage

Required: Stage I

Grade: low grade

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify